SpOvum at IHERA 2025: Showcasing Innovation in Embryology & ART Technologies

We were honored to be a part of the prestigious IHERA 2025 – 2nd International Conference on MicroEmb & ART 2.0, held on 24th and 25th May 2025 at The Park Hotel, Hyderabad. As one of the leading names in ART technology, SpOvum Technologies marked its presence not only as an exhibitor but also as a contributor to key scientific discussions shaping the future of human embryology.

Thought Leadership from the Founders

Our Co-Founders, Dr. Santosh Bhargav D B and Dr. Ramnath Babu T J, were invited as distinguished speakers at the event.

On 24th May, Dr. Santosh Bhargav D B, Co-Founder & CTO, presented an insightful talk titled “Role of Time-Lapse Monitoring in Fertilization Events.” In his session, he demonstrated how SpOvum’s AI-powered Time-Lapse Management Incubator is revolutionizing embryo assessment, offering clinicians deeper insights into fertilization dynamics and helping improve IVF outcomes.

On 25th May, Dr. Ramnath Babu T J, Co-Founder & CEO, delivered a visionary session on “ICSI – Robotics Redefining Micromanipulation.” He introduced RoboICSI, SpOvum’s groundbreaking robotic ICSI platform, showcasing how automation and precision engineering are setting new standards in micromanipulation procedures.

Engaging with the ART Community

SpOvum also hosted an engaging booth at the event, where ART professionals, embryologists, and clinic administrators experienced firsthand our range of smart ART technologies. Our team had the opportunity to connect, collaborate, and discuss practical challenges with the global fertility community.

IHERA 2025 was not just an event — it was a powerful reminder of how science, technology, and clinical practice can come together to shape the future of assisted reproduction. At SpOvum, we remain committed to pushing the boundaries of innovation and supporting fertility professionals with reliable, AI-integrated solutions.

Stay tuned as we continue our journey of enabling life through technology.

SpOvum Featured in E-Health Magazine: Our Director Shares Insights on Data Consistency in IVF Clinics

We are excited to share that Dr. Santosh Bhargav D B, Co-Founder and CTO of SpOvum Technologies, has been featured in the esteemed E-Health Magazine — a leading voice in the healthcare industry.

In his expert column, Dr. Santosh highlights the growing importance of Lab Management Systems (LMS) in ensuring data consistency across IVF clinics. With increasing demands for accuracy and regulatory compliance in Assisted Reproductive Technology (ART), Dr. Santosh shares how LMS platforms can revolutionise the way fertility labs manage samples, treatment records, and clinical processes.

From automated sample tracking to centralised data storage and role-based access control, the article offers practical insights on how the right technology can drive efficiency, reduce errors, and support better patient outcomes.

Read the full article here: https://ehealth.eletsonline.com/2025/04/maintaining-data-consistency-with-lab-management-systems-in-healthcare

We’re proud to see our thought leadership recognised in the healthcare space, and we remain committed to building innovative tech solutions for IVF and fertility care.

SpOvum Technologies Featured in BW Healthcare World: Insights from Our Co-Founder

We are thrilled to share that our Co-founder and CEO, Dr. Ramnath Babu T J, has been featured in BW Healthcare World with his insightful article on AI and automation in the Indian IVF industry.

AI & Automation: The Future of Indian IVF

With infertility affecting nearly 17.5% of the global population, the demand for Assisted Reproductive Technologies (ART) is on the rise. Dr. Ramnath Babu’s article highlights how AI-driven innovations are revolutionizing IVF procedures by enhancing embryo selection, improving success rates, and personalizing treatment.

India’s Push for AI in Healthcare

The Indian government’s IndiaAI Mission, a $1.25 billion initiative, aims to integrate AI across industries, including reproductive medicine. With regulations like the ART Regulation Bill, India is moving towards a standardized, ethical, and technology-driven IVF landscape.

Spreading Awareness & Adoption

Despite advancements, lack of awareness remains a major challenge. Fertility centers, including those supported by SpOvum, are leveraging digital outreach and AI-driven solutions to educate couples and streamline treatments.

Overcoming Challenges, Embracing Opportunities

While concerns like affordability, infrastructure, and ethical AI use persist, the future looks promising. AI has the potential to make IVF more efficient, affordable, and accessible, turning challenges into opportunities for aspiring parents.

We at SpOvum Technologies are committed to driving this transformation, supporting IVF clinics with innovative tech solutions. Read the full article on BW Healthcare World to explore how AI is shaping the future of fertility treatments.


Read the full article here: https://www.bwhealthcareworld.com/article/how-prepared-is-the-indian-ivf-industry-for-ai-automation-551596

SpOvum Featured in Indian Institute of Science (IISc) Research News for IVF Innovation

We are proud to announce that SpOvum Technologies has been featured in the Indian Institute of Science (IISc) Research News for our groundbreaking contributions to IVF and Assisted Reproductive Technology (ART). The article highlights our commitment to improving IVF success rates through advanced robotics and AI-driven solutions.

One of the key innovations covered in the feature is ROBO-ICSI, an automated system designed to enhance intracytoplasmic sperm injection (ICSI). Unlike traditional methods that require highly skilled embryologists to manually handle delicate procedures, ROBO-ICSI uses a robotic gripper to hold the oocyte (egg cell) with precision, reducing the risk of damage and improving fertilization outcomes.

Our Co-Founder and CEO, Dr. Ramnath Babu T J, shared insights on the critical need for data-driven and automation-based solutions in ART. With current IVF success rates averaging between 30-40%, SpOvum is focused on bridging the gap through innovations such as AI-assisted embryo selection, computer-aided semen analysis (CASA), and real-time monitoring systems to help clinicians make better-informed decisions.

The article also discusses how emerging technologies like electronic witnessing and AI-powered embryo evaluation are transforming fertility care, ensuring accuracy, reducing errors, and enhancing patient outcomes.

We are honored to be recognized by IISc for our contributions to reshaping the future of reproductive healthcare. Read the full feature here to explore how technology is driving the next phase of IVF advancements.

SpOvum at ISAR 2025: Pioneering Innovation in ART Technology

SpOvum Technologies proudly participated in ISAR 2025, Lucknow, showcasing groundbreaking advancements in Assisted Reproductive Technology (ART). From launching new products to engaging with industry experts, our presence at ISAR was all about innovation, collaboration, and the future of fertility technology.

Key Highlights from ISAR 2025

WhatsApp Bot for Instant Product Insights
Visitors at our booth engaged with SpOvum’s WhatsApp Bot, scanning the QR code to instantly receive detailed insights about our latest products. This seamless experience helped professionals explore our cutting-edge ART solutions effortlessly.

Exciting Product Launches & Showcases
SpOvum introduced several game-changing ART innovations, including:
Time Lapse Monitoring (TLM) – Revolutionizing embryo observation and incubation.
Lab Management System (LMS) – Optimizing lab workflows and efficiency.
Smart Alert & Smart Witness – IoT-powered lab monitoring for accuracy and security.
ART Dashboard & ART-GPT – AI-driven solutions for intelligent fertility care.

Leadership in Action: The Future of ICSI Innovation
Our Director, Dr. Ramnath Babu T J, delivered an insightful talk on “The Robotic Revolution: Where do we stand in ICSI innovation?” addressing the role of robotics in enhancing intracytoplasmic sperm injection (ICSI).

Engaging Booth Experience
SpOvum’s booth became a hub of innovation and interaction, drawing attention with our cutting-edge ART products. Our team actively engaged with fertility specialists, embryologists, and industry leaders, sharing how SpOvum is shaping the future of reproductive technology.

Looking Ahead

ISAR 2025 was a remarkable platform to showcase SpOvum’s commitment to ART innovation. We look forward to continuing our journey in transforming fertility care with AI, automation, and data-driven insights.

Instantly Access SpOvum Product Details via WhatsApp Bot

Explore SpOvum’s A.R.T. Innovations with Ease

At SpOvum, we are committed to making information about our cutting-edge A.R.T. solutions easily accessible. To enhance your experience, we’ve introduced a WhatsApp Bot designed specifically for ISAR 2025 attendees and beyond. With just a simple scan, you can receive instant details about our products, including key features, brochures, and specifications—right at your fingertips!

How to Use the WhatsApp Bot in 3 Easy Steps

Step 1: Scan the QR Code & Start Chat
Open your phone’s camera, scan the QR code provided at our booth, and initiate a WhatsApp chat.

Step 2: Send the Message
The bot will automatically generate the message: “Hello SpOvum, from ISAR 2025!” Simply hit send to begin.

Step 3: Select a Product
A list of SpOvum’s innovative A.R.T. solutions will appear. Choose any product to receive detailed information instantly.

Why Use the SpOvum WhatsApp Bot?

✅ Instant access to product details and brochures
✅ Hassle-free navigation—no need to browse multiple pages
✅ Available anytime, anywhere for quick reference

Experience the future of A.R.T. technology with SpOvum—scan, send, and explore!

Introduction to SpOvum TLM – Advancing Embryo Monitoring with AI

The SpOvum Time-Lapse Management System (TLM) is an innovative solution designed to revolutionize embryo monitoring in IVF. With continuous, AI-powered tracking, TLM enhances embryo selection, minimizes manual intervention, and improves overall success rates in fertility treatments.

Key features include:
Continuous embryo observation with minimal handling
High-resolution imaging using 12 dedicated 4K cameras
AI-driven insights for better embryo selection
Automated workflow for enhanced efficiency

Watch the video to see how SpOvum TLM is transforming Assisted Reproductive Technology (ART).

SpOvum Technologies Featured in BioSpectrum India for Revolutionizing IVF Workflows

We are delighted to share that SpOvum Technologies has been featured in BioSpectrum India for our groundbreaking advancements in IVF workflow management. The article highlights SpOvum’s efforts in introducing the Integrated IVF Management Solution, a first-of-its-kind system designed to transform IVF workflows through innovation and precision.

About the Coverage

BioSpectrum India’s article emphasizes how SpOvum is setting new standards in assisted reproductive technology (ART) by integrating advanced solutions like:

  • Real-Time Lab Monitoring: Ensuring lab health through continuous monitoring and reporting.
  • Smart Witness Technology: Guaranteeing traceability and accuracy in gamete and consumable management.
  • Comprehensive Data Integration: Seamlessly linking patient data with lab processes for better workflow efficiency.
  • Compliance with ART Regulations: Streamlining adherence to industry standards while safeguarding patient trust.

The article further explores how SpOvum’s innovative system enhances patient care, minimizes errors, and provides data-driven insights to optimize IVF treatment outcomes.

Key Highlights from the Article

  • Efficiency and Accuracy: SpOvum’s system simplifies administrative tasks while enabling better resource allocation, leading to improved clinical outcomes.
  • Enhanced Transparency: Real-time tracking of lab activities and patient data ensures compliance and builds trust.
  • Cost-Effective Solutions: Automated workflows reduce manual errors and operational costs, offering long-term savings for IVF clinics.

Transforming Fertility Care

SpOvum’s Integrated IVF Management Solution represents a significant leap forward in reproductive healthcare. By focusing on time-saving mechanisms, improved accuracy, and patient-centric care, we are committed to empowering IVF clinics with the tools they need to achieve excellence.

Read the Full Story

We extend our heartfelt gratitude to BioSpectrum India for recognizing our efforts and featuring our contributions to advancing IVF technologies.

To read the full article, visit BioSpectrum India

At SpOvum, we remain dedicated to revolutionizing fertility care through innovation and collaboration. This feature in BioSpectrum India reinforces our commitment to setting new benchmarks in the IVF and fertility industry.

Revolutionizing Fertility Care: SpOvum Featured in eHealth’s National Startup Day 2025 Story

National Startup Day 2025: Revolutionizing Fertility Care with AI and ML

We are thrilled to share that Dr. Ramnath Babu T J, Co-Founder and CEO of SpOvum Technologies, has been prominently quoted in eHealth Network’s article “National Startup Day 2025: Startups Shaping the Future of India’s Infertility with AI-ML.”

The article highlights the transformative role of startups in India’s fertility and IVF landscape, focusing on how AI and machine learning are reshaping reproductive healthcare. At SpOvum, we’re proud to be at the forefront of this revolution, enabling clinics to deliver better outcomes through advanced technology and innovation.

The Growing Need for Innovation in Fertility Care

Infertility affects 15–20% of couples in India, a number that has risen due to lifestyle changes, stress, and delayed childbearing. This rising trend emphasizes the urgent need for scientific, data-driven approaches to improve patient outcomes.

How AI and ML Are Transforming Fertility Treatments

The article sheds light on several areas where AI-ML technologies are making a difference in the fertility sector:

  • Improved Diagnostics: AI analyzes complex datasets to predict patient outcomes and identify underlying conditions, enabling better success rates.
  • Optimal Embryo Selection: By evaluating embryos on morphology and growth dynamics, AI ensures higher implantation rates.
  • Cryopreservation & Monitoring: AI enhances freezing and thawing processes for eggs and embryos, ensuring their viability.
  • Personalized Treatment Protocols: AI tailors treatment plans based on genetic, hormonal, and lifestyle data.
  • Automated Laboratory Workflows: AI-powered systems safeguard quality and reduce manual errors.

SpOvum’s Vision: Bridging the Gap in Fertility Care

Dr. Ramnath Babu emphasized the need for innovation and quality in India’s IVF industry. SpOvum’s technologies aim to set new benchmarks, ensuring that fertility treatments are effective and accessible across Tier 2 and Tier 3 cities.

A Milestone for SpOvum

We take immense pride in being part of the larger conversation around India’s health tech revolution. Dr. Ramnath’s insights in the eHealth article reflect SpOvum’s unwavering commitment to advancing fertility care through technology and innovation.

You can read the full article by eHealth Network here.

Dr. Santosh Bhargav Quoted in IndiaMed Today: Highlighting SpOvum’s Role in India’s Thriving Health Tech Ecosystem

We are delighted to share that our Director, Dr. Santosh Bhargav D B, has been quoted in IndiaMed Today’s industry story, “Reimagining Indian Healthcare 2024: The Pulsating Start-up Ecosystem.”

IndiaMed Today is a leading publication dedicated to covering innovations and trends in India’s healthcare sector. This feature article explores the transformative impact of health tech startups, which are reshaping the healthcare landscape with cutting-edge technologies like AI, machine learning, and data analytics. The story sheds light on the challenges and opportunities faced by startups in navigating funding landscapes, ensuring quality, and driving innovation.

In the article, Dr. Santosh Bhargav shares SpOvum’s journey and insights:

“The IVF industry is not yet accustomed to Made-in-India products. Our competitors have set high-quality standards, and we recognize the need to match and surpass these benchmarks. Innovating and improving upon established expectations requires substantial preparation, rigorous quality control, and dedicated effort. By investing in R&D, strengthening our quality assurance measures, and building strategic collaborations, we are positioning ourselves to achieve sustainable growth and resilience in the year ahead.”

Dr. Santosh’s thoughts reflect SpOvum’s commitment to excellence in the IVF domain, with a focus on delivering world-class solutions that meet and exceed global standards.

The Larger Context

The feature highlights that 2024 has been a pivotal year for health tech startups in India, with over $9.9 billion raised by July 2024. Startups like SpOvum, Even.in, Sunfox Technologies, and Dozee have not only overcome significant challenges but have also contributed to transforming healthcare delivery and accessibility.

As a homegrown startup, SpOvum is proud to be part of this dynamic ecosystem, continuously working to innovate and deliver meaningful impact in the field of Assisted Reproductive Technology (ART).

Read the full article on IndiaMed Today

%d bloggers like this: